FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - SubstancePolymer, Realm US

22,368 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

By Authority

 

Start Prev Rows 11000 - 11200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthUsage #
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.187.jsonInjectable Contraceptive HCPCS Provision Proceduresactive2021-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.188.jsonInjectable Contraceptive LOINCactive2021-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.189.jsonOral Contraceptive Pill SNOMED Surveillance Proceduresactive2021-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.190.jsonOral Contraceptive Pill SNOMED Provision Proceduresactive2021-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.191.jsonOral Contraceptive Pill SNOMED Findingsactive2021-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.193.jsonOral Contraceptive Pill ICD10CM Provision Encountersactive2021-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.194.jsonOral Contraceptive Pill ICD10CM Surveillanceactive2021-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.195.jsonOral Contraceptive Pill HCPCS Provision Proceduresactive2021-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.196.jsonOral Contraceptive Pill LOINCactive2021-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.197.jsonInjectable Contraceptive Provision Proceduresactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.198.jsonInjectable Contraceptive Surveillanceactive2021-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.199.jsonOral Contraceptive Pill Provision Proceduresactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.200.jsonOral Contraceptive Pill Surveillanceactive2021-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.201.jsonContraceptive Implant Devicesactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.202.jsonContraceptive Implant Provision Proceduresactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.203.jsonContraceptive Implant Surveillanceactive2021-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1166.96.jsonInfecund Not for Contraceptive Reasons SNOMED Findingsactive2021-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.10.jsonASN Screening Declinedactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.2.jsonIntracranial or Intraspinal surgeryactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.22.jsonEmergency Department Observationactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.27.jsonMental Health Diagnosis without Substance Use Disordersactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.28.jsonMental Health Diagnosis without Substance Use Disordersactive2025-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.29.jsonBed Assignedactive2024-05hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.3.jsonMalignant Intracranial Neoplasm Groupactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.31.jsonHealthcare Agent & Power of Attorney Documentationactive2024-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.32.jsonHealthcare Agent and Power of Attorney Documentationactive2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.33.jsonAdvance Directive Documentationactive2024-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.34.jsonAdvance Directive Documentationactive2024-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.35.jsonAdvance Directive Documentationactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.36.jsonPortable Medical Order(s) Documentationactive2024-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.37.jsonPortable Medical Order(s) Documentationactive2024-09hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.38.jsonAdvance Care Planning Discussion Documentationactive2024-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.4.jsonThrombolytic medicationsactive2021-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.40.jsonAdvance Care Planning Documentationactive2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.41.jsonAdvance Care Planning Documentationactive2024-09hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.42.jsonHealthcare Agent & Power of Attorney Documentationactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.43.jsonAdvance Directive Documentationactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.45.jsonAdvance Care Planning Documentationactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.46.jsonAdvance Care Planning Documentationactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.47.jsonPortable Medical Order(s) Documentationactive2024-10hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.48.jsonPortable Medical Order(s) Documentationactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.49.jsonIntervention for Positive Utility Insecurity Screenactive2024-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.5.jsonAllergy to thrombolyticsactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.50.jsonIntervention for Positive Utility Insecurity Screenactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.51.jsonIntervention for Positive Transportation Insecurity Screenactive2024-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.52.jsonIntervention for Positive Transportation Insecurity Screenactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.53.jsonIntervention for Positive Housing Instability Screenactive2024-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.54.jsonIntervention for Positive Housing Instability Screenactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.55.jsonIntervention for Positive Homelessness Screenactive2024-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.56.jsonIntervention for Positive Homelessness Screenactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.57.jsonNon Invasive Oxygen Therapy Device Codesactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.58.jsonGoals, preferences, and priorities for medical treatmentactive2025-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.6.jsonThrombolytics Adverse Eventactive2025-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1170.7.jsonIntraspinal surgeryactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1176.58.jsonFood Insecurity Screening Positiveactive2023-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.1.jsonEzetimibe Therapyactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.10.jsonAntihypertensive Medicationsactive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.100.jsonAllergy or Intolerance to ACE Medicationactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.101.jsonAllergy or Intolerance to ARB Medicationactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.102.jsonChronic Kidney Disease Stage 1active2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.103.jsonChronic Kidney Disease Stage 2active2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.104.jsonChronic Kidney Disease Stage 3active2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.105.jsonChronic Kidney Disease Stage 4active2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.106.jsonChronic Kidney Disease Stage 5active2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.107.jsonICD10 CM Chronic Kidney Disease Stage 1active2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.108.jsonICD10 CM Chronic Kidney Disease Stage 2active2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.111.jsonAHA GWTG Chronic Kidney Disease Stage 2active2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.112.jsonICD10 CM Chronic Kidney Disease Stage 3active2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.113.jsonICD10 CM Chronic Kidney Disease Stage 4active2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.114.jsonICD10 CM Chronic Kidney Disease Stage 5active2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.115.jsonAHA GWTG Chronic Kidney Disease Stage 1active2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.116.jsonAHA GWTG Chronic Kidney Disease Stage 3active2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.117.jsonAHA GWTG Chronic Kidney Disease Stage 4active2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.118.jsonSNOMED CT Atrial Fibrillationactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.119.jsonICD10 CM Atrial Fibrillationactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.121.jsonAHA GWTG Atrial Fibrillationactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.123.jsonSNOMED CT Hyperlipidemiaactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.124.jsonICD10 CM Hyperlipidemiaactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.125.jsonAHA GWTG Hyperlipidemiaactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.126.jsonSNOMED CT Hypertriglyceridemiaactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.127.jsonICD10 CM Hypertriglyceridemiaactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.129.jsonAHA GWTG Hypertriglyceridemiaactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.130.jsonSNOMED CT Gestational Diabetesactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.131.jsonICD10 CM Gestational Diabetesactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.132.jsonAHA GWTG Gestational Diabetesactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.133.jsonSNOMED CT Hyperglycemiaactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.134.jsonICD10 CM Hyperglycemiaactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.135.jsonAHA GWTG Hyperglycemiaactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.136.jsonSNOMED CT Nonobstructive CADactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.137.jsonICD10 CM Nonobstructive Coronary Artery Diseaseactive2024-12hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.138.jsonAHA GWTG Nonobstructive coronary artery diseaseactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.139.jsonAHA GWTG Anti Obesity Pharmacotherapyactive2024-12hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.15.jsonNon Tobacco Smoking Product Useractive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.16.jsonAntihypertensive Fixed Dose Combination Medicationsactive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.2.jsonPCSK9 Inhibitorsactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.20.jsonCCB and Thiazide and Thiazide Like Diureticsactive2021-01hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.21.jsonReferral to cardiac rehabactive2021-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.22.jsonCardiac Rehabilitationactive2021-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.25.json2 Hour Blood Glucose Testactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.26.jsonNYHA Functional Classificationactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.27.jsonARNI Therapyactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.29.jsonMRA Therapyactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.3.jsonCholesterol non HDL Laboratory Testactive2021-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.30.jsonSGLT2 Inhibitorsactive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.31.jsonHeart Transplantactive2022-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.32.jsonHeart Transplantactive2022-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.33.jsonHeart Transplantactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.34.jsonAllergy to MRA Therapyactive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.35.jsonAspirin or Clopidogrelactive2024-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.39.jsonCardiac Rehabilitationactive2024-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.4.jsonHypothyroidismactive2021-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.40.jsonCardiac Rehabilitationactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.43.jsonSGLT2 Ingredientsactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.44.jsonMRA Ingredientsactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.49.jsonMinnesota Living with Heart Failure Questionnaireactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.5.jsonHypothyroidismactive2024-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.50.jsonKansas City Cardiomyopathy Questionnaireactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.51.jsonCardiac Paceractive2021-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.52.jsonCardiac Paceractive2025-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.53.jsonCardiac Paceractive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.54.jsonHeart Transplant Complicationsactive2022-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.55.jsonHeart Transplant Complicationsactive2025-01hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.56.jsonHeart Transplant Complicationsactive2022-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.57.jsonLeft Ventricular Assist Device Complicationsactive2022-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.58.jsonLeft Ventricular Assist Device Complicationsactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.59.jsonLeft Ventricular Assist Device Placementactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.6.jsonHypothyroidismactive2021-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.60.jsonLeft Ventricular Assist Device Placementactive2023-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.61.jsonLeft Ventricular Assist Device Placementactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.62.jsonLeft Ventricular Assist Device Placementactive2022-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.63.jsonHeart Transplantactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.65.jsonCardiac Paceractive2022-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.66.jsonDiastolic Heart Failureactive2023-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.67.jsonDiastolic Heart Failureactive2023-06hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.68.jsonDiastolic Heart Failureactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.69.jsonAllergy to SGLT2 Inhibitorsactive2023-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.7.jsonAnorexia Nervosaactive2023-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.70.jsonIntolerance to SGLT2 Inhibitorsactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.71.jsonIntolerance to MRA Therapyactive2022-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.72.jsonARNI Ingredientactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.73.jsonMitral Stenosisactive2022-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.74.jsonMitral Stenosisactive2022-02hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.75.jsonMitral Stenosisactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.76.jsonMechanical Prosthetic Heart Valveactive2022-11hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.77.jsonMechanical Prosthetic Heart Valveactive2025-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.78.jsonMechanical Prosthetic Heart Valveactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.79.jsonMechanical Prosthetic Heart Valve in Situactive2022-02hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.8.jsonAnorexia Nervosaactive2021-04hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.82.jsonSystolic Heart Failureactive2023-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.83.jsonSystolic Heart Failureactive2023-03hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.84.jsonSystolic Heart Failureactive2023-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.85.jsonCarotid Interventionactive2023-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.86.jsonSerum Creatinineactive2023-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.87.jsonUrine Creatinineactive2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.88.jsonUrine Albuminactive2023-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.9.jsonAnorexia Nervosaactive2021-04hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.90.jsonNon Steroidal Mineralcorticoid Receptor Antagonistactive2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.91.jsonGlucagon like peptide 1 medicationsactive2024-11hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1178.96.jsonAHA GWTG Long COVID19active2024-10hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.1.jsonWound internal item and/or body structure visible value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.11.jsonWound exudate appearance value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.12.jsonWound exudate color value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.13.jsonExudate odor value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.16.jsonSkin temperature value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.17.jsonSkin color enumerated value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.18.jsonSkin turgor value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.19.jsonSkin and mucous membrane integrity value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.2.jsonPeriwound condition value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.20.jsonSkin moisture value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.3.jsonWound Type Etiology value setactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.4.jsonWound episode value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.6.jsonWound bed appearance value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.60.jsonWound type reference setactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.7.jsonWound bed color value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.74.jsonNonverbal pain indicators reference setactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.76.jsonPain associated signs and symptoms reference setactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.77.jsonPain body location reference setactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.8.jsonWound edge description value set (foundation metadata concept)active2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.80.jsonPain quality reference setactive2025-03hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.81.jsonPain speed of onset reference setactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1181.9.jsonPresence absence value set (foundation metadata concept)active2018-07hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1186.1.jsonCommon drug substances for allergy and intolerance documentationactive2024-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1186.2.jsonCommon drug classes for allergy and intolerance documentationactive2024-06hl7
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1186.3.jsonCommon dietary substances for allergy and intolerance documentationactive2024-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1186.4.jsonCommon environmental substances for allergy and intolerance documentationactive2024-06hl72
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.10.jsonNHSNCriterionOfDiagnosisCode(CDCNHSN)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.11.jsonNHSNCriterionOfDiagnosisCode(SNOMEDCT)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.12.jsonNHSNInfectionConditionCode(CDCNHSN)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.13.jsonNHSNInfectionConditionCode(SNOMEDCT)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.14.jsonNHSNInfectionTypeCode(CDCNHSN)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.15.jsonNHSNInfectionTypeCode(SNOMEDCT)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.16.jsonNHSNInfectionFirstReportedSource(CDCNHSN)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.17.jsonNHSNInfectionFirstReportedSource(SNOMEDCT)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.18.jsonNHSNLOS/MENDischargeDisposition(CDCNHSN)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.19.jsonNHSNLOS/MENDischargeDisposition(SNOMEDCT)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.20.jsonNHSNPopulationSummaryReportTypeCode(CDCNHSN)active2020-08hl73
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.21.jsonNHSNPopulationSummaryReportTypeCode(LOINC)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.22.jsonNHSNSameDayOutcomeMeasure(CDCNHSN)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.23.jsonNHSNSameDayOutcomeMeasure(SNOMEDCT)active2020-08hl71
us.nlm.vsacR4ValueSet/ValueSet-2.16.840.1.113762.1.4.1190.24.jsonNHSNSignificantPathogenCode(CDCNHSN)active2020-08hl71